Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.
Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...
Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming ...
Spray-dried protein microparticles without MoNi surfactant form paste-like materials (left), whereas those spray dried with MoNi surfactant form injectable suspensions that flow like liquids (right).
Senate Judiciary Committee member Sen. John Cornyn, R-Tex., has sponsored a bill to crack down on an anticompetitive practice called prescription drug product hopping. (AP Photo/Alex Brandon) In 2014, ...
This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...
The biopharmaceutical industry stands on the cusp of a revolution, with artificial intelligence (AI) emerging as a transformative force in drug development. AI's ability to reduce the time and cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results